Chunmeng Wang - Concepedia

Author

Chunmeng Wang

Chinese PLA General Hospital ORCID

Also Known As

Chun-Meng Wang, Chun-meng Wang, Chunmeng Wang

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Chinese PLA General Hospital Johns Hopkins University Chinese People's Liberation Army China Pharmaceutical University People's Liberation Army No. 150 Hospital

About

Chunmeng Wang is an author at Chinese PLA General Hospital specializing in immunology, medicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	36
2	Engineering	1	1	20
3	Natural Sciences	1	1	19
4	Allergy	1	1	17
5	Biomolecular Engineering	1	1	20

Chunmeng Wang

Publications

Citations

H-Index

Page 1

	Year	Citations
Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial Chunmeng Wang, Zhiqiang Wu, Yao Wang, Clinical Cancer Research	2016	323
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia Hanren Dai, Zhiqiang Wu, Hejin Jia, Journal of Hematology & Oncology	2020	312
Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B cell lymphoma Chuan Tong, Yang Liu, Xingyu Ji, Blood	2020	272
Addition of Low-Dose Decitabine to Anti–PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma Jing Nie, Chunmeng Wang, Yang Liu, Journal of Clinical Oncology	2019	214
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia Hanren Dai, Wenying Zhang, Xiaolei Li, OncoImmunology	2015	164
Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report Wenying Zhang, Yao Wang, Yelei Guo, Signal Transduction and Targeted Therapy	2016	130
Long-term activity of tandem CD19/CD20 CAR therapy in refractory/relapsed B-cell lymphoma: a single-arm, phase 1–2 trial Yao Wang, Yang Liu, Chuan Tong, Leukemia	2021	91
Decitabine priming increases anti–PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models Xiang Li, Yaru Li, Liang Dong, Journal of Clinical Investigation	2023	65
Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma Yang Liu, Chunmeng Wang, Xiang Li, Journal for ImmunoTherapy of Cancer	2021	63
Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma Yao Wang, Chuan Tong, Yuting Lu, Signal Transduction and Targeted Therapy	2023	50

Page 1